Product Information
EFFER-K 10 MEQ TABLET EFF is a generic product labeled by Nomax Inc., priced at $0.4545 per EA under NDC 51801001430. Its NADAC has been published 429 times since Feb 18, 2015.
Strength
391 mg/1
Manufacturer
Nomax Inc.NDC
51801001430
Classification
Generic
Dosage Form
TABLET, EFFERVESCENT
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
POTASSIUM BICARBONATEApproval Type
Unapproved
On Market Since
1/30/2013
Pharmacological Classes
Price Statistics
The NADAC for EFFER-K 10 MEQ TABLET EFF has been published 429 times since Feb 18, 2015, and over the history we have for it it has risen 34.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4545 per EA |
|---|---|
| All-time high | $0.4565 (Feb 11, 2026) |
| All-time low | $0.3190 (Sep 21, 2016) |
| 52-week high | $0.4565 |
| 52-week low | $0.4468 |
| Median price | $0.3827 |
| Average price | $0.3892 |
| Largest weekly change | +16.9% (Apr 17, 2024) |
| Weeks tracked | 429 |
| Tracking since | Feb 18, 2015 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Nomax Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
POTASSIUM BICARBONATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Osmotic Laxative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of EFFER-K 10 MEQ TABLET EFF?
The current National Average Drug Acquisition Cost (NADAC) for EFFER-K 10 MEQ TABLET EFF, manufactured by Nomax Inc., is $0.4545 per EA (NDC 51801001430), effective Sep 30, 2026.
How has the price of EFFER-K 10 MEQ TABLET EFF changed over time?
Over the history we have for it, the NADAC for EFFER-K 10 MEQ TABLET EFF has risen 34.3%. It has been tracked across 429 weekly CMS publications since Feb 18, 2015.
What are the highest and lowest recorded NADAC prices for EFFER-K 10 MEQ TABLET EFF?
Since Feb 18, 2015, the NADAC for EFFER-K 10 MEQ TABLET EFF has ranged from a low of $0.3190 (Sep 21, 2016) to a high of $0.4565 (Feb 11, 2026), with a median of $0.3827 per EA.
Are there cheaper alternatives to EFFER-K 10 MEQ TABLET EFF?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as EFFER-K 10 MEQ TABLET EFF in a comparable dosage form, but none are currently priced below it.
Who manufactures EFFER-K 10 MEQ TABLET EFF?
EFFER-K 10 MEQ TABLET EFF (NDC 51801001430) is labeled by Nomax Inc., and CMS classifies it as a generic product.